We are live on
!
Find out more
CIC
Cornercap Investment Counsel Portfolio holdings
AUM
$203M
1-Year Est. Return
17.67%
This Fund
S&P 500
This Quarter
Est. Return
+2.8%
1 Year Est. Return
+17.67%
3 Year Est. Return
+55.44%
5 Year Est. Return
+79.88%
10 Year Est. Return
+193.02%
AUM
$575M
AUM Growth
+$7.13M
(+1.3%)
Cap. Flow
-$3.73M
Cap. Flow
% of AUM
-0.65%
Top 10 Holdings %
Top 10 Hldgs %
8.61%
Holding
700
New
139
Increased
152
Reduced
171
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$3M |
| 2 |
Paycom
PAYC
|
+$2.19M |
| 3 |
Salesforce
CRM
|
+$2.04M |
| 4 |
PPG Industries
PPG
|
+$2.01M |
| 5 |
Walmart Inc
WMT
|
+$1.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$3.36M |
| 2 |
Comcast
CMCSA
|
+$3.32M |
| 3 |
AbbVie
ABBV
|
+$2.94M |
| 4 |
Amgen
AMGN
|
+$2.18M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$1.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.22% |
| 2 | Financials | 16.95% |
| 3 | Healthcare | 13.98% |
| 4 | Industrials | 13.52% |
| 5 | Consumer Discretionary | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Herbalife
HLF
$1.21B
| $261K | 0.05% |
19,697
| – | – |
|
477
J.M. Smucker
SJM
$12.6B
| $258K | 0.04% |
1,745
+25
| +1% | +$3.81K |
|
478
Vir Biotechnology
VIR
$1.5B
| $255K | 0.04% |
10,378
| – | – |
|
479
Metropolitan Bank Holding Corp
MCB
$1.15B
| $253K | 0.04% |
7,281
-276
| -4% | -$8.3K |
|
480
Amphenol
APH
$207B
| $252K | 0.04% |
5,940
| – | – |
|
|
IMA
481
ImageneBio Inc
IMA
$64.9M
| $252K | 0.04% |
3,196
-92
| -3% | -$6.6K |
|
482
Intellia Therapeutics
NTLA
$1.68B
| $251K | 0.04% |
6,156
| – | – |
|
483
Akamai
AKAM
$16.9B
| $247K | 0.04% |
2,747
-21,120
| -88% | -$1.81M |
|
484
ALX Oncology
ALXO
$285M
| $246K | 0.04% |
+32,783
| New | +$215K |
|
485
Starbucks
SBUX
$119B
| $245K | 0.04% |
2,471
| – | – |
|
486
Regenxbio
RGNX
$688M
| $241K | 0.04% |
+12,074
| New | +$233K |
|
487
Dyne Therapeutics
DYN
$4.95B
| $239K | 0.04% |
+21,235
| New | +$251K |
|
488
Broadcom
AVGO
$2.01T
| $237K | 0.04% |
+2,730
| New | +$195K |
|
489
Synchrony
SYF
$25.4B
| $235K | 0.04% |
6,916
-173
| -2% | -$5.28K |
|
490
Hewlett Packard
HPE
$72.4B
| $234K | 0.04% |
13,956
-47,272
| -77% | -$723K |
|
|
LIAN
491
DELISTED
LianBio American Depositary Shares
LIAN
| $233K | 0.04% |
102,237
-63,163
| -38% | -$145K |
|
492
Olema Pharmaceuticals
OLMA
$1.04B
| $229K | 0.04% |
25,330
-25,822
| -50% | -$156K |
|
493
Iovance Biotherapeutics
IOVA
$2.9B
| $226K | 0.04% |
32,164
-5,519
| -15% | -$39.5K |
|
|
KLRS
494
Kalaris Therapeutics
KLRS
$93.7M
| $225K | 0.04% |
2,883
+1,166
| +68% | +$111K |
|
495
Rollins
ROL
$17.9B
| $223K | 0.04% |
5,200
-24,301
| -82% | -$988K |
|
496
Corvus Pharmaceuticals
CRVS
$1.16B
| $223K | 0.04% |
+97,248
| New | +$202K |
|
|
LONA
497
LeonaBio Inc
LONA
$70.5M
| $222K | 0.04% |
7,525
| – | – |
|
498
Air Products & Chemicals
APD
$68.6B
| $222K | 0.04% |
740
| – | – |
|
499
Vanda Pharmaceuticals
VNDA
$304M
| $217K | 0.04% |
+33,003
| New | +$212K |
|
500
MeiraGTx Holdings
MGTX
$1.21B
| $216K | 0.04% |
32,203
| – | – |
|
Similar funds
NWM
EECFX
PSB
HIA
NMG
EECFX
BC
EFA
Cornercap Investment Counsel's Q2 2023 Portfolio in Review
As of Q2 2023, Cornercap Investment Counsel held 700 positions worth $575M, up 1.3% from $568M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
Cornercap Investment Counsel's Q2 2023 filing shows 139 new, 152 increased, 171 reduced and 133 closed positions. Its largest new stake was Walt Disney: 31,661 shares worth $2.83M. The largest sale was Wells Fargo, an estimated $3.36M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Cornercap Investment Counsel's largest Q2 2023 buy was Walt Disney: 31,661 shares worth $2.83M.
- Cornercap Investment Counsel added most to MSCI in Q2 2023, an estimated $1.63M increase.
- Cornercap Investment Counsel's biggest Q2 2023 reduction was Edwards Lifesciences, cutting an estimated $1.86M.
- Cornercap Investment Counsel fully exited Wells Fargo in Q2 2023, selling an estimated $3.36M.
- Cornercap Investment Counsel's ten largest holdings make up 8.6% of its $575M portfolio in Q2 2023.
- Cornercap Investment Counsel opened 139 new positions and closed 133 in Q2 2023.
- Cornercap Investment Counsel's portfolio value rose 1.3% quarter-over-quarter to $575M.
Based on Cornercap Investment Counsel's 13F filing for Q2 2023, filed 11 Aug 2023.